If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 10 Oct: IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa
• 19 Aug: World Mosquito Day 2025: A new world, crises, and opportunities
• 6 Oct: DR-TB regimen will save 190,000+ additional lives and $1.29B by 2035
• 18 Sep: New Study Finds Investing in Shorter, More Effective TB Treatment Pays Off
• 18 Aug: Japan commits new funding to develop treatments for drug-resistant infections
• 26 Jun: Dapivirine vaginal ring recommended as an HIV prevention option for adolescent girls
• 2 Sep: Turning trust into coverage: Youth-led efforts raise malaria vaccine uptake
• 8 Sep: Strengthening Africa’s health R&D and manufacturing ecosystem: Analysis of the investments and gaps
• 6 Oct: First patient enrolled in historic Phase 3 clinical trial to treat malaria in first-trimester pregnancy
• 7 Oct: Coartem® Baby launches in Ghana
• 13 Oct: MMV joins WHO-led Global Clinical Trials Forum as part of its commitment to equitable and inclusive research
• 24 Sep: Co-creating an innovative AI platform to advance global health research
• 3 Oct: DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
• 15 Sep: Switzerland renews commitment to DNDi to advance medical innovation for neglected patients
• 11 Sep: FIND announces appointment of Dr Jutta Reinhard-Rupp as Chief Scientific Officer
• 12 Sep: FIND appoints Henri Mwaniki as Chief Financial Officer
• 10 Sep: IVI joins WHO Coalition of Interested Parties Network
• 13 Oct: IVI joins WHO’s new Global Clinical Trials Forum
• 14 Aug: EVI begins clinical trial for promising malaria vaccine in Burkina Faso
MDGH
PDP Funder News/Announcements
• 3 Oct: The Global Fund works—these stories remind us why it’s essential. Gates Foundation
• 5 Oct: Advancing new and underused innovations to end preventable death in childbirth. Unitaid
• 17 Oct: Ambassador Anne Claire Amprou appointed new Chair of Unitaid’s Executive Board. Unitaid
• 18 Sep: America First Global Health Strategy. US Department of State
• 22 Sep: With Millions of Children’s Lives on the Line, Bill Gates Says Humanity Is at a Crossroads. Gates Foundation
• 22 Sep: New European Partnership on One Health AMR: €253 million for research and innovation against antimicrobial resistance. European Commission
• 24 Sep: Unitaid, CHAI, and Wits RHI enter into a landmark agreement with Dr. Reddy’s to make HIV prevention tool lenacapavir affordable in LMICs. Unitaid
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• Oct: Initiatives on Reimagining Global Health Architecture: A Primer. Spark Street Advisors
• 9 Oct: 2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people. Access to Medicines Foundation
• Oct: Forecasting global demand for novel TB vaccines: scenarios for early planning and needs assessment. Gavi & CHAI
• 13 Oct: No eradication without innovation: the EU at a crossroads to eliminate HIV/AIDS, TB, and malaria. Global Health Advocates
Related Press Releases/ Announcements/Articles
• 1 Oct: Trump cuts: Gaps in drug research funding in Europe can’t be filled, experts warn. BMJ
• 1 Sep: Mitigating antimicrobial resistance by innovative solutions in AI (MARISA): a modified James Lind Alliance analysis. Nature
• 1 Sep: Pan American Health Organization Targeted in New Round of US Funding Cut. Health Policy Watch
• 1 Sep: Nigeria Scales Up Mpox Prevention with Targeted Vaccination in High-Burden States. WHO
• 1 Sep: To stop disease X, we must invest in African health. The Telegraph
• 1 Sep: Due south: navigating volatile health research landscapes. The Lancet HIV
• 1 Sep: HIV is on the rise among older Africans, but care and research overlook this group – lessons from Kenya and South Africa. The Conversation
• 1 Sep: Climate change could reprogram malaria mosquitoes. Institute of Tropical Medicine Antwerp
• 1 Sep: Oxford launches major new AI vaccine research programme with the Ellison Institute of Technology. University of Oxford
• 1 Sep: Pharmaceutical Knowledge Commons for the Most Neglected Populations in Global Health: The Drugs for Neglected Diseases initiative. Oxford Academic
• 2 Oct: WHO releases new reports on new tests and treatments in development for bacterial infections. WHO
• 2 Oct: Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025. WHO
• 2 Oct: Broader access urged for affordable HIV drug. SciDevNet
• 2 Sep: USAID's 'final mission' has just ended. Now what?. Devex
• 2 Sep: Opinion: Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine research. The Lancet Microbe
• 2 Sep: The UK as a Global Partner of Choice for R&D – will it catch on?. HEPI
• 2 Sep: The utility of infectious disease modelling in informing decisions for outbreak response: A scoping review. PLOS Global Public Health
• 2 Oct: Babies' deaths in Cameroon show how US aid cuts curtail malaria fight. Reuters
• 2 Oct: New study shows all-in-one coronavirus vaccines could save millions of lives in future pandemics. CEPI
• 2 Oct: WHO says the antibacterial pipeline reveals a dual crisis: scarcity and lack of innovation. STAT
• 3 Oct: AI has designed thousands of potential antibiotics. Will any work?. Nature
• 3 Oct: Reports identify weakness in global pipeline for new antibiotics, diagnostics. CIDRAP
• 3 Oct: WHO: Conditions ripe for further chikungunya spread. CIDRAP
• 3 Oct: Why Ending Malaria Depends on Bold Financing and Global Leadership. Health Policy Watch
• 3 Oct: In the maraña of leishmaniasis. The Lancet Infectious Diseases
• 3 Oct: From Promise To Practice: Delivering On The WHO Pandemic Agreement. Health Affairs
• 3 Oct: The Pandemic Fund and the Next Global Health Crisis. Observer Research Foundation
• 3 Oct: Comparison of major, minor and junctional circumsporozoite protein epitopes for malaria vaccine design. Nature Vaccines
• 3 Oct: Ghana launches Coartem 'baby' to strengthen fight against malaria in infants. Modern Ghana
• 3 Oct: Operationalizing African self-reliance in vaccine manufacturing. Global Health Action
• 3 Oct: AVAC Input for Recompetition of the NIAID HIV/AIDS Clinical Trials Networks. AVAC
• 4 Oct: HIV community welcomes lenacapavir deal. The Lancet
• 4 Oct: QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants. Science Direct
• 4 Sep: Developing Countries Outline Contours of the Pathogen Access Benefits Sharing System for Global Health. Geneva Health Files
• 4 Sep: New Ebola Outbreak Confirmed in the Democratic Republic of Congo. Africa CDC
• 4 Sep: Mpox exposes fundamental obstacles for vaccinating children in outbreaks. BMJ
• 4 Sep: At least 15 dead in Ebola outbreak in DRC. The Telegraph
• 4 Sep: Democratic Republic of the Congo declares Ebola virus disease outbreak in Kasai Province. WHO
• 4 Sep: The World Needs a Medical-Research Overhaul. Project Syndicate
• 4 Sep: Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug. NPR
• 4 Sep: Dividends from death: Rapid autopsies on people infected with HIV may help researchers find a cure. Science
• 4 Sep: A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial. The Lancet
• 4 Sep: Shaping opportunities for future clinical trials in tuberculosis. The Lancet
• 5 Oct: Tailoring malaria control interventions to suit local context: codesign of perennial malaria chemoprevention (PMC) programmes through the Plus Project. BMJ
• 6 Oct: First lenacapavirs prequalified. WHO
• 6 Oct: How research access drives public health innovation. Springer Nature
• 6 Oct: CEPI backs new research into vaccines against multiple deadly filoviruses. CEPI
• 6 Oct: Helen Clark named as new Chair of the Gavi Board. Gavi
• 6 Oct: 2024 was a record-setting year for lifesaving vaccines. Vox
• 6 Oct: Mali Enrols First Pregnant Patient in Malaria Trial. Health Policy Watch
• 6 Oct: The role of outdoor mosquito management in malaria control. Devex
• 6 Oct: The global health landscape will never be the same — and it shouldn’t be. Devex
• 6 Oct: Permethrin-treated wraps cut malaria rates in babies by 66%. CIDRAP
• 6 Oct: The Fallout From the Dismantling of USAID Continues. Newsweek
• 6 Oct: The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance. CGD
• 6 Oct: Unpacking the US’s New Global Health Strategy: Retreating When We Could Be Winning. CGD
• 7 Oct: Promise and gaps in America First strategy for global health. BMJ
• 7 Oct: Ghanaian Newborns First to Get New Malaria Medication. Health Policy Watch
• 7 Oct: CEPI partners with AVAREF to boost clinical trial application reviews in Africa. CEPI
• 7 Oct: The rise of ‘nightmare bacteria’: antimicrobial resistance in five charts. Nature
• 7 Oct: The Emerging Resistance Index: tracking early resistance to new antibiotics. The Lancet
• 7 Oct: Household transmission of mpox in Africa: limited in adults but more prevalent in children. The Lancet
• 7 Oct: Xpert-Ultra for diagnosing asymptomatic tuberculosis. The Lancet
• 7 Oct: Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study. The Lancet
• 7 Oct: WHO launches the Global Clinical Trials Forum. WHO
• 7 Oct: Babies take a lesson from soldiers in the war against malaria. NPR
• 8 Oct: WHO says Ebola outbreak in Congo shows signs of containment with no new cases reported. Reuters
• 8 Oct: Genetic diversity and natural selection of circumsporozoite surface protein in Vietnam Plasmodium falciparum isolates. Malaria Journal
• 8 Oct: The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy. Nature Vaccines
• 8 Oct: Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial. The Lancet HIV
• 8 Oct: Dolutegravir in neonates: finally we are getting there!. The Lancet HIV
• 8 Oct: Stronger, faster, fairer: making mpox vaccines accessible. CEPI
• 8 Oct: Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. NEJM
• 8 Oct: ‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge. The New York Times
• 8 Oct: UK launches new aid inquiry in response to 40% budget cut. Devex
• 9 Oct: Africa must lead its own health research revolution. SciDevNet
• 9 Oct: The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV
• 9 Oct: Elucidated protein structures in the malaria parasite offer opportunities for new vaccines. MedicalXpress
• 9 Oct: Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people. STAT
• 9 Oct: In Kaduna, Nigeria, all hands are on deck to fight an mpox outbreak. Gavi
• 9 Oct: The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?. BHEKISISA
• 9 Oct: US aid cuts are being felt across Africa. Here’s where.. The Washington Post
• 9 Oct: Ebola vaccine safe for mothers and infants. Nature
• 9 Oct: China joining COVAX boosts bid to ensure fair access to vaccine - GAVI tells Reuters. Reuters
• 10 Oct: Looming Malaria Drug Resistance Spurs Global Search for New Treatments. Health Policy Watch
• 10 Oct: Rapid diagnostics test can detect asymptomatic malaria cases. Imperial College
• 10 Oct: Major foundation pauses grants to US, citing unclear policy changes. Devex
• 10 Oct: Statement on the Launch of African Manufacturing Market Intelligence & Network Analysis (AMMINA). Africa CDC
• 10 Oct: Decolonising women’s health innovation. The BMJ
• 11 Oct: Two for two: lenacapavir during pregnancy and lactation. The Lancet
• 11 Oct: CDC battered by government shutdown firings, while some are rescinded. STAT
• 11 Sep: Low-research settings: is there a need for specific attention from funders?. BMJ Global Health
• 11 Sep: Cuts threaten UK leadership on global health research, MPs told. Science Business
• 11 Sep: Experts warn loss of USAID endangers the fight against deadly TB. CIDRAP
• 11 Sep: TB is the No. 1 killer among infectious diseases. A new study says its toll could mount. NPR
• 12 Oct: BMJ Group launches global call to close the women’s health gap and transform innovation. BMJ Group
• 12 Oct: BMFTR boosts international vaccine initiative CEPI. CEPI
• 13 Oct: WHO warns of widespread resistance to common antibiotics worldwide. WHO
• 13 Oct: A new antibiotic is positive news—but it will take more to stay ahead of superbugs. BMJ
• 13 Oct: Innovation in medicines for global health: a 20-year landscape analysis. Nature Drug Discovery
• 13 Oct: Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds. The Guardian
• 13 Oct: EIB and European Commission join forces with BioNTech to build a sustainable vaccine ecosystem in Africa. Science Business
• 13 Oct: How do recurrent malaria infections occur in clinical cohorts: a mathematical modelling study to support study planning. Malaria Journal
• 13 Oct: Germany commits €1B to Global Fund as aid cuts shape World Health Summit. Devex
• 13 Oct: Foreign Aid Is Mostly Gone. It Could Be Replaced With Something Better. The New York Times
• 13 Oct: Antimicrobial resistance, equity and justice in low- and middle-income countries: an intersectional critical interpretive synthesis. Nature
• 14 Oct: CEPI announces new partnership with Indian vaccine maker. CEPI
• 14 Oct: One in Six Bacterial Infections Is Antibiotic Resistant; Calls for Stronger Real-Time Pandemic Risk Surveillance. Health Policy Watch
• 14 Oct: As new infections outpace new drugs, are we sleepwalking into a global health disaster?’. The Guardian
• 14 Oct: BioNTech's African mRNA vaccine production push gets EU funding boost. Fierce Pharma
• 14 Oct: Novo Nordisk Foundation pledges up to $31M to support AI-powered pandemic preparedness platform. Fierce Biotech
• 14 Oct: Report proposes new framework to prepare for future pandemics. CIDRAP
• 14 Oct: POST introduction evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021. Malaria Journal
• 14 Oct: Africa imports over 70% of its medicines. Making active ingredients locally would change this. Gavi
• 14 Oct: Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1. CEPI
• 14 Oct: Stop playing catch-up with superbugs: the anticipatory governance of antimicrobial resistance. WEF
• 15 Oct: Forecasting global demand for life-saving TB vaccines. CHAI
• 15 Oct: Antimalarial resistance deserves higher priority in global AMR strategy. Oxford Centre for Tropical Medicine & Global Health
• 15 Oct: Haphazard US CDC staff cuts leave questions around impact. Devex
• 16 Sep: Turning Against Vaccines, America Is a Global Outlier. The New York Times
• 16 Oct: Low-cost vaccine vial monitors damaging heat exposure brought to market. MedicalXpress
• 16 Oct: Chikungunya, spreading fast this year, visits Mombasa for a third time. Gavi
• 16 Oct: The US and Europe have cut billions in health aid — can anyone fill the gap?. Nature
• 16 Oct: Global Health Leaders Urge Fewer Agencies Amid Funding Crisis. Health Policy Watch
• 16 Oct: Machine learning advances drug discovery through generalizable models. News Medical
• 16 Sep: NIH funds new center focused on preventing drug-resistant infections. CIDRAP
• 17 Oct: Drive to include pregnant and breastfeeding women and children in clinical trials. Health Policy Watch
• 17 Oct: New Monoclonal Antibody Shows Promise for Preventing Malaria Infections. Newswise
• 17 Oct: Physicians’ knowledge of, and willingness to encourage caregivers to partake in the RTS S/AS01 and R21 matrix M malaria vaccines roll out – a national survey in Nigeria. BMC Infectious Diseases
• 17 Sep: Africa CDC's rocky road to stability. Devex
• 17 Sep: The destruction of USAID is already leading to a trickle-down demise. Devex
• 17 Sep: The Global Status of PEPFAR Delivery. CGD
• 17 Sep: CRISPR-based tongue swab test shows promise for tuberculosis detection. News Medical
• 17 Sep: Analyzing USAID Program Disruptions: Implications for PEPFAR Programming and Beneficiaries. CGD
• 18 Oct: Preserving clinical skills in the age of AI assistance. The Lancet
• 18 Oct: New monoclonal antibody prevents malaria infection in early clinical trial. MedicalXpress
• 18 Sep: New US global health plan prioritizes drugs, recipients' self-reliance. Reuters
• 18 Sep: Genetic clues to how malaria-carrying mosquitoes evade control identified. The Irish News
• 18 Sep: WHO says 31 of 38 Ebola cases in Congo have resulted in deaths. STAT
• 18 Sep: DR Congo Ebola cases rise as outbreak response gains traction. CIDRAP
• 18 Sep: Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons. Frontiers in Immunology
• 18 Sep: NIH outlines new system for awarding research grants to foreign scientists. STAT
• 18 Sep: New NIH grant supports development of experimental pediatric HIV vaccine. News Medical
• 18 Sep: Genetic study reveals how Anopheles funestus adapts to malaria control. News Medical
• 18 Sep: Trump administration’s new global health aid strategy focuses on bilateral deals with countries. STAT
• 18 Sep: PEPFAR’s Next Chapter: From the Ashes, a Path for Constructive US Global Health Engagement?. CGD
• 18 Sep: What’s broken in global health, and how do we fix it?. Devex
• 18 Sep: Liverpool scientists lead discovery of powerful new antibiotic class to tackle deadly superbugs. University of Liverpool
• 19 Oct: Trump is cutting foreign aid. He’s not the only one. Politico
• 19 Sep: Private Foundations and Global Health Governance A Case Study of the Novo Nordisk Foundation. UN University
• 19 Sep: How Mpox revealed an epidemic of untreated HIV in Sierra Leone – as Trump’s aid cuts begin to bite. The Independent
• 19 Sep: A need for new tools for prevention of malaria in pregnancy. PLOS
• 19 Sep: The New America First Global Health Strategy: Three Observations. Think Global Health
• 19 Sep: Building a global AI platform for pandemic preparedness. CEPI
• 19 Sep: ‘America First’ Global Health Strategy Commits to Funding Medicines and Health Workers – In Time-Limited, Bilateral Deals. Health Policy Watch
• 19 Sep: The Trump Administration’s response to Congo’s Ebola outbreak isn’t normal, infectious disease leaders say. NOTUS
• 19 Sep: A Mathematical Model for Malaria with Human and Vector Controls in Nigeria. Springer Nature
• 19 Sep: Amended International Health Regulations enter into force. WHO
• 19 Sep: Report: National action plans on antimicrobial resistance have had no impact on antibiotic sales. CIDRAP
• 20 Oct: Insights into malaria parasite's sodium pump structure could reshape treatment. Phys.org
• 22 Sep: A new RNA tool is speeding up the fight against sleeping sickness. Institute Pasteur
• 22 Sep: Africa CDC Unveils $3.2 Billion Plan to Transform Vaccine and Drug Production. Addis Insight
• 22 Sep: Urgent support needed to prevent Ebola spreading in Congo, says Red Cross federation. Reuters
• 21 Oct: Anti-malaria funding cuts could lead to ‘deadliest resurgence ever’, study warns. The Guardian
• 22 Sep: Africa CDC earmarks Shs11 trillion to boost local drug manufacturing. The Monitor
• 22 Sep: The ripple effect: how global health R&D delivers for everyone. Impact for Global Health
• 22 Sep: Expanding horizons to improve lives. NovoNordisk Foundation
• 22 Sep: What's in — and what's missing — in the new U.S. strategy for global health. NPR
• 22 Sep: Harnessing Africa’s untapped clinical trial potential. Access to Medicine Foundation
• 23 Sep: Eight secrets to making sense of scientific studies. Gavi
• 23 Sep: 14 African countries explore innovative financing solutions for health in the African region. WHO
• 23 Sep: Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial. The Lancet
• 23 Sep: Introduction and roll-out of malaria vaccine in Sierra Leone: early lessons and experiences from the first 8 months of implementation. The Lancet
• 23 Sep: Ebola outbreak in the DRC: why is it so deadly?. Nature
• 23 Sep: New study find treatment for Chagas disease is excessive. Centre for Tropical Medicine and Global Health
• 23 Sep: DRC Ebola outbreak puts neighbours on high alert. Gavi
• 23 Sep: US lab data show sharp increase in superbug incidence. CIDRA
• 23 Sep: New European Partnership on One Health AMR: €253 million for research and innovation against antimicrobial resistance. Public Now
• 23 Sep: ‘The Elders’ Highlight Global Leadership Vacuum Amid Climate and Pandemic Threats. Health Policy Watch
• 24 Sep: Permethrin-Treated Baby Wraps for the Prevention of Malaria. NEJM
• 24 Sep: Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response. CIDRAP
• 24 Sep: Ebola outbreak in DR Congo adds 11 new cases in past week. CIDRAP
• 24 Sep: Insecticide-Treated Baby Wraps Ward Off Malaria. MedPage Today
• 24 Sep: Global health groups push to make cheap generic versions of an HIV prevention drug sold by Gilead. STAT
• 24 Sep: Global Fund Celebrates Private Sector Pledges Exceeding US$1 Billion on Sidelines of UN General Assembly. The Global Fund
• 24 Sep: Global health reimagined: proposed functions, structures, and forms from five regions. The Lancet
• 24 Sep: 90% of rich countries' global health R&D goes to domestic institutions. Devex
• 24 Sep: New partnerships bring price parity between lenacapavir and oral PrEP. Devex
• 24 Sep: Trump's 'America First' global health plan sidelines NGOs. Devex
• 24 Sep: Financing for Future Pandemics: Three Strategic Shifts We Need Now. CGD
• 24 Sep: Exclusive: RFK Jr cancelled mRNA research — but the US military is still funding it. Nature
• 24 Sep: What role will Africa CDC play in an ‘America First’ global health vision?. Devex
• 24 Sep: Realising the potential of AI for diagnostics in Africa: From barriers to scalability. ECDPM
• 24 Sep: America First in Global Health: How Africa Should Respond. Think Global Health
• 24 Sep: Promising treatment for leishmaniasis disease found in Okinawan marine sponges. Phys.org
• 24 Sep: Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response. CIDRAP
• 24 Sep: Africa CDC Welcomes UK’s Formal Approval of Direct Funding Following Successful Due Diligence Assessment. Africa CDC
• 25 Sep: Joint statement on strengthening clinical trials 2025. WHO
• 25 Sep: Diagnostic firm Rapidemic receives $2.7M Gates Foundation grant. 360Dx
• 25 Sep: “An act of health justice”: Guinea's children receive the malaria vaccine. Gavi
• 25 Sep: Ebola vaccines, malaria complexity, tracing maize, mapping infrastructure, and controlling schistosomiasis. Nature Africa
• 25 Sep: Member States advance vital work in support of WHO Pandemic Agreement. WHO
• 25 Sep: After U.S. Retreat, Europe Recasts Its Role in Global Health. Think Global Health
• 25 Sep: 'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines. Fierce Biotech
• 25 Sep: Updated WHO dashboard offers new insights on antimicrobial resistance and use. WHO
• 25 Sep: Devex CheckUp: HIV prevention drug lenacapavir is about to get cheaper in 2027. Devex
• 25 Sep: A revolutionary HIV drug won't matter if patients can't afford it. Devex
• 26 Sep: Bangladesh bets on British vaccine in bid to wipe out malaria. The Telegraph
• 26 Sep: NIH pulled off a ‘near miracle.’ Scientists say there’s still a problem. The Washington Post
• 26 Sep: Supreme Court rules that Trump administration can let foreign aid expire. Devex
• 27 Sep: WHO Staff in Geneva Call for Freeze In Layoffs and Independent Review of Downsizing Plans. Health Policy Watch
• 27 Sep: Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine. The Journal of Medicine Access
• 29 Sep: Better late than never: defining the ideal vaccine that targets pre-erythrocytic malaria infection. EMBO Press
• 29 Sep: Gaps in the global health research landscape for mpox: an analysis of research activities and existing evidence. BMC Medicine
• 29 Sep: Experts welcome Trump’s “America first” global health strategy. BMJ
• 29 Sep: The top grantees of Wellcome. Devex
• 29 Sep: Why beating malaria is smart business for America. Devex
• 29 Sep: New one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond. Rice University
• 29 Sep: With USAID gone, do foundations still care about localization?. Devex
• 30 Sep: Africa’s ‘meningitis belt’ has killed hundreds of thousands – a new vaccine may turn the tide. The Telegraph
• 30 Sep: African Nations Review Mpox Response. All Africa
• 30 Sep: Could a new coalition around saving lives be the way forward?. Devex
• 30 Sep: Drug development for neglected diseases must account for kids. Nature
• 30 Sep: The American brain drain: How a US retreat from research is driving innovators abroad. GHTC
Upcoming Meetings/ Webinars
--------------------------